Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cenegermin-bkbj (oxervate) (1 trial)
sodium chloride (1 trial)
Cerebral Infarction (Phase 4)
Ischemia (Phase 4)
Stroke (Phase 4)
Trials (1 total)
Trial APIs (2 total)